MOESM6 of Impact of aromatase inhibitor treatment on global gene expression and its association with antiproliferative response in ER+ breast cancer in postmenopausal patients

MLA

Gao, Qiong, et al. MOESM6 of Impact of Aromatase Inhibitor Treatment on Global Gene Expression and Its Association with Antiproliferative Response in ER+ Breast Cancer in Postmenopausal Patients. Jan. 2020. EBSCOhost, https://doi.org/10.6084/m9.figshare.11490957.v1.

APA

Gao, Q., Lã, pez-K. E., Cheang, M., Morden, J., Ribas, R., Kally Sidhu, Evans, D., Martins, V., Dodson, A., Skene, A., Holcombe, C., Mallon, E., Evans, A., Bliss, J., Robertson, J., Smith, I., Lesley-Ann Martin, & Dowsett, M. (2020). MOESM6 of Impact of aromatase inhibitor treatment on global gene expression and its association with antiproliferative response in ER+ breast cancer in postmenopausal patients. https://doi.org/10.6084/m9.figshare.11490957.v1

Chicago

Gao, Qiong, pez-Knowles, Elena Lã, Maggie Cheang, James Morden, Ricardo Ribas, Kally Sidhu, David Evans, et al. 2020. “MOESM6 of Impact of Aromatase Inhibitor Treatment on Global Gene Expression and Its Association with Antiproliferative Response in ER+ Breast Cancer in Postmenopausal Patients,” January. doi:10.6084/m9.figshare.11490957.v1.